BCAB Competitors & Alternatives
Compare Bioatla Inc with similar stocks in the same industry
Biotechnology
BCAB
Main Stock$3.91
Tradestie Score
56
Market Cap
$39.57M
Revenue Growth
0.3%
Analyst Upside
+155.8%
Top Competitors
233 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
AVTX
Avalo Therapeutics, Inc. Common Stock
|
$18.91
|
$170.45M | - | 58 | Compare |
|
ACHV
Achieve Life Sciences, Inc.
|
$6.10
|
$158.43M | - | 57 | Compare |
|
NVCT
Nuvectis Pharma, Inc. Common Stock
|
$18.44
|
$154.27M | - | 52 | Compare |
|
CCCC
C4 Therapeutics, Inc.
|
$3.92
|
$153.02M | - | 53 | Compare |
|
CLYM
Climb Bio, Inc. Common Stock
|
$13.21
|
$133.50M | - | 66 | Compare |
|
STTK
Shattuck Labs, Inc. Common Stock
|
$6.43
|
$114.01M | - | 61 | Compare |
|
ANRO
Alto Neuroscience Inc.
|
$28.03
|
$110.20M | - | 63 | Compare |
|
ALXO
ALX Oncology Holdings Inc. Common Stock
|
$1.97
|
$96.93M | - | 64 | Compare |
|
RLMD
Relmada Therapeutics, Inc. Common Stock
|
$6.45
|
$71.69M | - | 54 | Compare |
|
IMMX
Immix Biopharma, Inc. Common Stock
|
$10.52
|
$67.94M | - | 61 | Compare |
More BCAB Analysis
Data updated: Jul 13, 2026 | Industry: Biotechnology (SIC 2836)
233 stocks in this industry